Chandra Bhattacharya In The News
PhRMAFoundation
Chandrabali Bhattacharya, PhD, of the 51吃瓜网万能科大, is developing a platform for in vivo CAR T cell therapy, which could have a tremendous impact on the field of cancer immunotherapy.
